Get a glimpse into our company and investor data—powered by the PitchBook Platform
M&ALATEST DEAL TYPE
Developer of pharmaceuticals products. The company develops needle-free, non-inhaled insulin delivery technology which involves suspension of macro-molecular drugs, such as insulin to facilitate systemic delivery via the buccal membrane.
Corporate Backed or Acquired
Vectoris Pharma Valuation and Funding
This information is reserved for PitchBook Platform users. To explore Vectoris Pharma‘s full profile, request access.